Wildeboer Dellelce LLP acted for CTI on the matter. Cytophage Technologies Ltd. (“Cytophage”), formerly Cuspis Capital III Ltd., has completed a reverse take-over (the “RTO”) of…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Sonia Carcano
…
This content is for Standard 1 Year members only. LoginJoin Now